Europe — EMA

Oxaliplatin Kabi

Oxaliplatin, the active ingredient in Oxaliplatin Kabi, is a platinum compound presented as a strength/form for intravenous use. It treats colorectal cancer and is used in adult patients.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Kabi, is a platinum compound presented as a strength/form for intravenous use. It treats colorectal cancer and is used in adult patients. GNH USA supplies Oxaliplatin Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Kabi is a platinum‑based chemotherapy agent used in the treatment of cancers that arise from the gastrointestinal tract.

- Colorectal cancer: Improves the overall response to combination chemotherapy regimens in patients with metastatic disease. - Gastric cancer: Used as part of a mult‑

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →